W. Lloyd Sanders

Who is W. Lloyd Sanders?

Mr. Sanders heads Genta's worldwide commercial operations. He has almost 20

years of commercial pharmaceutical experience. Prior to joining Genta,

Mr. Sanders held key leadership positions in the commercial

organizations of Pharmacia (now Pfizer), Sanofi-Synthelabo and

subsequently Sanofi-Aventis. He most recently served as

Vice-President, Oncology Sales, for Sanofi-Aventis. In that role, he

had key product sales responsibility for Eloxatin® (oxaliplatin),

Taxotere® (docetaxel), Anzemet® (dolasetron mesylate), and ELITEK®

(rasburicase). He led the successful restructuring, integration,

deployment, strategic development, and tactical execution of the merged

companies’ sales forces. He was responsible for national account GPO

contracting strategy and negotiations, and he shared responsibility for

oncology sales training and sales operations. At Sanofi-Synthelabo, he

led the 110-member team that achieved record sales for an oncology

product launch with Eloxatin® (oxaliplatin). From 1987 until 2002, Mr.

Sanders held progressively increasing levels of responsibility at

Pharmacia, Inc. (now Pfizer) participating in the launches of

Camptosar® (irinotecan) and ELLENCE® (epirubicin). Mr. Sanders holds a

Bachelor of Business Administration from Memphis State University.